Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise.
作者信息
Stensland Kristian D, Krischak Madison K, Bank Merrick, Sekar Rishi R, Lewicki Patrick, Piatt Gretchen A, Ghani Khurshid, Herrel Lindsey A, Barnes Geoffrey D, Odell David D, Skolarus Ted A
机构信息
Department of Urology, University of Michigan, Ann Arbor, Michigan.
Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan.
出版信息
Urol Pract. 2024 Jul;11(4):627-629. doi: 10.1097/UPJ.0000000000000598. Epub 2024 May 8.
Abstract
摘要
相似文献
1
Estimating the Size and Scope of the Urologic Oncology Clinical Trials Enterprise.评估泌尿外科肿瘤学临床试验项目的规模和范围。
Urol Pract. 2024 Jul;11(4):627-629. doi: 10.1097/UPJ.0000000000000598. Epub 2024 May 8.
2
Open clinical uro-oncology trials in Canada.加拿大的开放性临床泌尿肿瘤学试验。
Can J Urol. 2009 Oct;16(5):4875-81.
3
The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.泌尿外科肿瘤学不断变化的格局：启动全身治疗、介入技术与临床试验。引言。
Urol Oncol. 2012 Jul-Aug;30(4 Suppl):S1. doi: 10.1016/j.urolonc.2012.05.003.
4
[Active studies of the Working Association for Urological Oncology (AUO) in 2006].[2006年泌尿肿瘤学工作协会（AUO）的正在进行的研究]
Urologe A. 2006 Feb;45(2):229-40. doi: 10.1007/s00120-006-1002-1.
5
Open clinical uro-oncology trials in Canada.加拿大的开放性临床泌尿肿瘤学试验。
Can J Urol. 2011 Dec;18(6):6054-9.
6
Open clinical uro-oncology trials in Canada.加拿大的开放性临床泌尿肿瘤学试验。
Can J Urol. 2008 Aug;15(4):4223-8.
7
Developments in urologic oncology 'OncoForum': The best of 2014.泌尿肿瘤学进展“肿瘤论坛”：2014年精华
Actas Urol Esp. 2015 Jun;39(5):271-8. doi: 10.1016/j.acuro.2015.02.004. Epub 2015 Mar 12.
8
Defining the publication source of high-quality evidence in urology: an analysis of EvidenceUpdates.界定泌尿外科高质量证据的出版来源：对“证据更新”的分析
BJU Int. 2016 Jun;117(6):861-6. doi: 10.1111/bju.13392. Epub 2016 Jan 9.
9
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology.将姑息治疗原则纳入泌尿科肿瘤学，以改善患者护理和生活质量。
Nat Rev Urol. 2021 Oct;18(10):623-635. doi: 10.1038/s41585-021-00491-z. Epub 2021 Jul 26.
10
National and Location-Specific Medicare Physician Fee Reimbursement Trends in Urologic Oncology From 2002 to 2024.2002年至2024年美国国家及特定地区泌尿外科肿瘤学领域医疗保险医师费用报销趋势
Urol Pract. 2025 Jul;12(4):380-390. doi: 10.1097/UPJ.0000000000000795. Epub 2025 Mar 5.
本文引用的文献
1
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
Envisioning clinical trials as complex interventions.将临床试验视为复杂干预措施。
Cancer. 2022 Sep 1;128(17):3145-3151. doi: 10.1002/cncr.34357. Epub 2022 Jun 29.
3
Estimating the rate and reasons of clinical trial failure in urologic oncology.估算泌尿肿瘤学临床试验失败的速率和原因。
Urol Oncol. 2021 Mar;39(3):154-160. doi: 10.1016/j.urolonc.2020.10.070. Epub 2020 Nov 27.
4
Clinical Trials in Urology: Predictors of Successes and Failures.泌尿外科临床试验：成功与失败的预测因素。
J Urol. 2020 Oct;204(4):805-810. doi: 10.1097/JU.0000000000001072. Epub 2020 Apr 7.
Zotero 插件